Thermo Fisher Scientific (TMO) Non-Current Debt (2009 - 2026)

Thermo Fisher Scientific has reported Non-Current Debt for 18 years, with the latest figure at $42.3 billion in Q2 2026.

• Non-Current Debt for Q2 2026 came in at $42.3 billion, up 20.7% year-over-year; the trailing twelve-month figure through Jun 2026 was $42.3 billion (up 20.7% YoY), and the FY2025 annual result was $39.2 billion, up 26.07% from the prior year.
• Non-Current Debt fell to $42.3 billion in Q2 2026, from $42.9 billion in the prior quarter.
• Over five years, Non-Current Debt peaked at $42.9 billion in Q1 2026 and troughed at $28.9 billion in Q4 2022.
• A 5-year average of $35.0 billion and a median of $35.0 billion in 2023 frame the typical range for Non-Current Debt.
• The widest annual swing landed in 2022, when Non-Current Debt jumped 77.31%; it then declined 10.52% in 2024.
• A 5-year view of Non-Current Debt shows it stood at $34.3 billion in 2022, then grew by 1.31% to $34.7 billion in 2023, then dropped by 10.52% to $31.1 billion in 2024, then increased by 26.07% to $39.2 billion in 2025, then grew by 7.94% to $42.3 billion in 2026.
• Per Business Quant data, the three most recent Non-Current Debt figures were $42.3 billion in Q2 2026, $42.9 billion in Q1 2026, and $39.2 billion in Q4 2025.